期刊文献+

2型糖尿病患者人体成分的变化 被引量:10

Changes of body compositions in patients with type 2 diabetes mellitus
原文传递
导出
摘要 目的了解2型糖尿病患者与正常人体内成分的差异,进一步探讨肥胖与2型糖尿病的关系。方法随机选取80例2型糖尿病患者(糖尿病组)及80例健康体检者(对照组),分别进行人体成分分析,包括体脂肪、内脏脂肪区域、骨骼肌、腰臀比及蛋白质、矿物质含量等指标,同时测定糖尿病患者的血糖、血脂、胰岛素抵抗指数、糖化血红蛋白。结果糖尿病组体脂肪[(19.68±6.78)kg]、体脂百分比[(29.87±8.04)%]、肥胖程度[(115.93±15.94)%]、内脏脂肪区域[(104.48±36.19)cm。]、体质量指数[(24.85±3.51)ks/m。]、胸围[(94.06±7.86)cm]、腰围[(85.18±9.50)cm]、腰臀比(0.90±0.05)均明显高于对照组[体脂肪:(17.31±5.55)kg、体脂百分比:(27.38±6.47)%、肥胖程度:(108.88±13.80)%、内脏脂肪区域:(85.44±44.04)cm2、体质量指数:(23.43±3.10)kg/m2、胸围:(91.11±7.52)em、腰围:(80.79±8.17)cm、腰臀比(0.86±0.05)](t值分别为2.55、2.30、3.12、2.86、2.73、2.28、3.12、4.76,P均〈0.05),而体质量控制[(-7.01±7.49)kg]、肥胖控制[(-8.53±6.66)kg]、肌肉控制[(1.52±1.43)kg]均低于对照组[体质量控制:(-4.08±6.79)蚝、肥胖控制:(-6.39±5.78)kg、肌肉控制:(2.31±2.09)kg(t值分别为-2.59、-2.17、-2.15,P均〈0.05)。糖尿病组尿酸与体质量控制、肥胖控制呈负相关(r值分别为-0.43、-0.42,P均〈0.01),与内脏脂肪区域、体脂百分比、腰臀比、体质量指数、肥胖程度、胸围、腰围、体脂肪呈正相关(r值分别为0.32、0.31、0.40、0.36、0.36、0.31、0.42、0.42,P均〈0.05),甘油三酯与体质量控制、肥胖控制呈负相关(r值分别为-0.44、-0.41,P均〈0.01),与体脂百分比、腰臀比、体质量指数、肥胖程度、胸围、腰围、体脂肪呈正相关(r值分别为0.27、0.35、0.46、0.46、0.35、0.42、0.42,P均〈0.05)。结论2型糖尿病患者的体脂肪含量及体脂肪分布与健康人有显著差异,中心性肥胖可能与糖尿病发生存在一定关系。 Objective To compare the body composition of diabetic and healthy subjects and to investigate the correlation between obesity and type 2 diabetes mellitus. Methods Body composition was analyzed in 80 type 2 diabetic patients ( diabetes group) and 80 healthy subjects ( control group) selected at random. They were measured for body fat mass, visceral fat area, sketedtal muscle mass, waist-hip ratio, the content of protein and mineral, etc. The blood glucose, blood fat, insulin resistance index (Homa-IR) and glycosylated hemoglobin(HbAlc) were also measured. Results The means of body fat mass( ( 19. 68 ±6.78) kg), percent body fat ( ( 29. 87 ± 8.04 ) % ), obesity degree ( ( 115.93 ± 15.94 ) % ), visceral fat area ( ( 104. 48 ± 36. 19) cm2 ), Body mass index (BMI) ( (24. 85 ± 3.51 ) kg/m2 ), chest circumference ( (94.06 ± 7. 86) cm), waist circumference ( ( 85.18 ± 9. 50) cm) and waist-hip ratio (0. 90 ± 0. 05 ) were significantly higher than the means of healthy subjects'weight control( ( -4. 08 ±6. 79) kg) ,body fat mass( ( 17. 31 ±5.55) kg), percent body fat ( (27. 38 ± 6.47 )% ), obesity degree ( ( 108.88 ± 13. 80 )% ), visceral fat area ( (85.44 ± 44. 04) cm2) ,BMI( (23.43 ±3.10) kg/m2) ,chest circumference( (91.11 ±7.52) cm) ,waist circumference ( (80. 79 ± 8. 17) cm) and waist-hip ratio (0. 86 ± 0.05 ) ( t = 2. 55,2. 30,3.12,2. 86,2. 73,2. 28,3.12 and 4. 76 respectively; P 〈 0. 05 ), body mass control ( ( - 7. 01 ± 7.49 ) kg), obesity control ( ( - 8. 53 ± 6. 66 ) kg) ,muscles control( ( 1.52 ± 1.43 ) kg) were lower than control group :the body mass control( ( - 4. 08 ± 6. 79) kg), obesity control ( ( - 6. 39 ± 5.78 ) kg), muscles control ( ( 2. 31 ± 2.09 ) kg). The uric acid was negatively related to weight control and obesity control ( r = - 0. 43, - 0. 42 ; P 〈 0.01 ), and were positively related to visceral fat area, percent body fat, waist-hip ratio, BMI, obesity degree, chest circumference, waist circumference and body fat mass ( r = 0. 32,0. 31,0. 40, 0. 36, 0. 36, 0. 31,0. 42,0. 42; P 〈 0.05 ) . The triglyceride was negatively related to weight control and obesity control( r = -0. 44,-0. 41 ;P 〈 0. 01 ), and were positive related to percent body fat, waist-hip ratio, BMI, obesity degree, chest circumference, waist circumference and body fat mass(r =0. 27,0. 35,0. 45,0. 46,0. 35,0. 42,0. 42;P 〈0. 05). Conclusion The body fat and fat distribution are significantly different between diabetic and healthy subjects. There may be some relationship between central obesitv and diabetes.
出处 《中国综合临床》 2013年第3期232-236,共5页 Clinical Medicine of China
关键词 2型糖尿病 人体成分分析仪 中心性肥胖 Type 2 diabetes mellitus Body composition Central obesity
  • 相关文献

参考文献19

二级参考文献148

共引文献364

同被引文献95

  • 1侯曼,刘静民.用生物电阻抗法测量人体体成分及分析[J].中国运动医学杂志,2005,24(1):89-92. 被引量:74
  • 2薛筷明,吴龙珠.肥胖与阻塞性睡眠呼吸暂停综合征关系的研究[J].护理研究,2005,19(7):1179-1180. 被引量:7
  • 3胡晓抒,郭志荣,武鸣,张均,孙国祥,周正元,周慧,姚才良.体重指数、腰围与代谢性健康风险的关系[J].中华流行病学杂志,2005,26(12):967-970. 被引量:62
  • 4周建军.某社区女性居民糖尿病与空腹血糖损害现状及影响因素研究[J].上海预防医学,2006,18(8):374-376. 被引量:1
  • 5Qiao Q, Laatikainen T, Zethelius B, et al. Comparison of definitions of metabolic syndrome in relation to the risk of developing stroke and coronary heart disease in Finnish and Swedish cohorts [ J ]. Stroke, 2009,40 ( 2 ) : 337-343.
  • 6Hermansen K, Davies M, Derezinski T, et al. A 26-week, randomized,parallel, treat-to-target trim comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes [J]. Diabetes Care, 2006,29 (6) : 1269-1274.
  • 7Boland CL, Degeeter M, Nuzum DS, et al. Evaluating second-line treatment options for type 2 diabetes:focus on secondary effects of GLP-1 agonists and DPP-4 inhibitors [J]. Ann Pharmacother, 2013,47(4) :490-505.
  • 8Kim M, Platt M J, Shibasaki T, et al. GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressur [J]. Nat Med,2013,19(5) :567-575.
  • 9Flint A, Kapitza C, Zdravkovic M. The once-daily human GLP-1 analogue liraglutide impacts appetite and energy intake in patients with type 2 diabetes after short-term treatment [ J ]. Diabetes Obes Metab ,2013,15 (10) :958-962.
  • 10Ponzani P. Long-term effectiveness and safety of liraglutide in clinical practice [J]. Minerva Endocrinol,2013,38( 1 ) :103-112.

引证文献10

二级引证文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部